Carson Wealth (CWM LLC)’s Serina Therapeutics SER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-6
Closed 4494
2023
Q1
$0 Buy
+6
New +$138 ﹤0.01% 4377
2022
Q2
Sell
-6
Closed 4133
2022
Q1
$0 Hold
6
﹤0.01% 3916
2021
Q4
$0 Buy
+6
New +$162 ﹤0.01% 3670
2021
Q2
$0 Hold
9
﹤0.01% 3022
2021
Q1
$0 Hold
9
﹤0.01% 3020
2020
Q4
$0 Hold
9
﹤0.01% 3017
2020
Q3
$0 Hold
9
﹤0.01% 3016
2020
Q2
$0 Hold
9
﹤0.01% 3014
2020
Q1
$0 Hold
9
﹤0.01% 3011
2019
Q4
$0 Hold
9
﹤0.01% 3009
2019
Q3
$0 Hold
9
﹤0.01% 3009
2019
Q2
$0 Hold
9
﹤0.01% 3008
2019
Q1
$0 Sell
9
-34
-79% -$4.97K ﹤0.01% 3313
2018
Q4
$5K Buy
+43
New +$5.47K ﹤0.01% 1555

Other funds holding SER

Carson Wealth (CWM LLC)'s SER Position: Q2 2023 in Review

Carson Wealth (CWM LLC) sold out of Serina Therapeutics (SER) in Q2 2023, closing a stake of 6 shares.

Carson Wealth (CWM LLC) first reported a position in SER in Q4 2018 and held it in 14 quarters. The position peaked at $5K in Q4 2018. 32 funds tracked by Wall St. Rank hold SER as of Q2 2023.

  • Carson Wealth (CWM LLC) reported no remaining Serina Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Carson Wealth (CWM LLC) sold 6 Serina Therapeutics shares in Q2 2023.
  • Carson Wealth (CWM LLC) first reported a position in Serina Therapeutics in Q4 2018 and held it in 14 quarters.
  • Carson Wealth (CWM LLC)'s Serina Therapeutics position peaked at $5K in Q4 2018.
  • 32 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2023.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q2 2023, filed 3 Aug 2023.